Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

518.60
-4.9300-0.94%
Post-market: 518.00-0.6000-0.12%19:53 EDT
Volume:963.11K
Turnover:501.31M
Market Cap:56.01B
PE:13.15
High:528.37
Open:525.77
Low:516.10
Close:523.53
Loading ...
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 07, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 03, 2022

Major Issues Report

8-K - Current report
Aug 03, 2022

Major Issues Report

8-K - Current report
Aug 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 15, 2022

Major Issues Report

8-K - Current report
Jun 02, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Major Issues Report

8-K - Current report
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 08, 2022

Major Issues Report

8-K - Current report
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2022

Major Issues Report

8-K - Current report
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities